Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 2 hours 8 min ago

Kaltura: Disappointing Trends And Over-Reliance On M&A (Downgrade)

Thu, 04/23/2026 - 13:21

The Contrarian View On Credo Technology

Thu, 04/23/2026 - 13:21

The longer oil prices remain elevated, the longer stocks will correct – Fidelity’s Jurrien Timmer

Thu, 04/23/2026 - 13:20

Palo Alto on track to log losses after six-session rally

Thu, 04/23/2026 - 13:20

EWP: Expect A Slow Tourism Season Amid Surging Fuel Costs And Weak Consumer Sentiments

Thu, 04/23/2026 - 13:17

United Rentals signals 2026 free cash flow of $2.15B-$2.45B while lifting revenue outlook to $16.9B-$17.4B

Thu, 04/23/2026 - 13:12

United Rentals, Inc. 2026 Q1 - Results - Earnings Call Presentation

Thu, 04/23/2026 - 13:12

Molina signals 2026 premium revenue of ~$42B and at least $5 EPS while lifting Medicaid attrition outlook to 6%

Thu, 04/23/2026 - 13:12

PCA expects $2.33 in Q2 2026 EPS excluding special items as price benefits build into Q3

Thu, 04/23/2026 - 13:12

Markets Are Stuck In The Waiting For U.S.-Iran Talks

Thu, 04/23/2026 - 13:05

Huntington Bancshares upgraded to Neutral at Piper as positives increase

Thu, 04/23/2026 - 13:03

CenterPoint reiterates 2026 non-GAAP EPS $1.89-$1.91 as Houston Electric firmly committed load rises to 12.2 GW

Thu, 04/23/2026 - 13:03

WEX forecasts $2.82B-$2.88B 2026 revenue and $18.95-$19.55 adjusted EPS, while planning $50M in cost-saving actions

Thu, 04/23/2026 - 13:03

Lam Research: The AI Upcycle Is Real, But The Price Is Too Expensive

Thu, 04/23/2026 - 13:03

Oceaneering reaffirms 2026 EBITDA of $390M-$440M with $1B Q1 order intake amid Middle East uncertainty

Thu, 04/23/2026 - 13:02

AT&T: Broadband Remains A Gem

Thu, 04/23/2026 - 12:59

CrowdStrike ends six-day winning streak; shares fall

Thu, 04/23/2026 - 12:58

JPMorgan plans to deploy capital into commercial banking loans - report

Thu, 04/23/2026 - 12:58

What is next for Netflix after its Q1 guidance selloff?

Thu, 04/23/2026 - 12:55

Immunology drug developer Odyssey seeks U.S. IPO again

Thu, 04/23/2026 - 12:52

Pages